×

Uh-oh, it looks like your Internet Explorer is out of date.

For a better shopping experience, please upgrade now.

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Alternative view 1 of Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Alternative view 2 of Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Alternative view 3 of Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
<Previous >Next
     

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

by Jack Cush
 

See All Formats & Editions

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon.

Overview

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Product Details

ISBN-13:
9781455750597
Publisher:
Elsevier Health Sciences
Publication date:
11/15/2012
Series:
Clinics: Internal Medicine
Sold by:
Barnes & Noble
Format:
NOOK Book
Pages:
240
File size:
4 MB

Related Subjects

Customer Reviews

Average Review:

Post to your social network

     

Most Helpful Customer Reviews

See all customer reviews